世界の肺動脈高血圧(PAH)治療市場2016

【英語タイトル】Global Pulmonary Arterial Hypertension (PAH) Therapeutics Market Research Report 2016

QYResearchが出版した調査資料(QYR61224868)・商品コード:QYR61224868
・発行会社(調査会社):QYResearch
・発行日:2016年11月3日
・ページ数:110
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD2,900 ⇒換算¥327,700見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD5,800 ⇒換算¥655,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※当調査レポートでは、世界の肺動脈高血圧(PAH)治療市場について調査・分析し、市場概観、市場動向、肺動脈高血圧(PAH)治療の世界市場規模、市場予測、地域別市場規模(日本市場、中国市場、米国市場、欧州市場など)、用途別市場分析、製造コスト分析、主要なメーカー分析(企業概要、主な製品概要、生産・販売動向、連絡先など)、種類別価格分析、価格情報、市場環境分析、輸出・輸入データ、市場シェア分析などを含め、以下の構成でお届けいたします。

・肺動脈高血圧(PAH)治療の世界市場:市場概要
・肺動脈高血圧(PAH)治療の世界市場:市場動向
・肺動脈高血圧(PAH)治療の世界市場:市場規模、市場規模予測
・肺動脈高血圧(PAH)治療の地域別市場規模(日本市場、中国市場、アメリカ市場、ヨーロッパ市場など)
・肺動脈高血圧(PAH)治療の世界市場:用途別市場分析
・肺動脈高血圧(PAH)治療の製造コスト分析
・肺動脈高血圧(PAH)治療の企業間競争状況
・肺動脈高血圧(PAH)治療の主要なメーカー分析(企業情報、主な製品概要、生産・販売動向、連絡先など)
・肺動脈高血圧(PAH)治療の種類別価格分析
・肺動脈高血圧(PAH)治療の価格動向
・肺動脈高血圧(PAH)治療の世界市場:市場環境分析
・肺動脈高血圧(PAH)治療の世界市場:輸出・輸入データ
・肺動脈高血圧(PAH)治療の世界市場:市場シェア分析
・肺動脈高血圧(PAH)治療の世界市場:結論
...
【レポートの概要】

Notes:Production, means the output of Pulmonary Arterial Hypertension (PAH) Therapeutics
Revenue, means the sales value of Pulmonary Arterial Hypertension (PAH) Therapeutics

This report studies Pulmonary Arterial Hypertension (PAH) Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Actelion Pharmaceuticals Ltd. (Switzerland)
Arena Pharmaceuticals, Inc. (US)
Bayer HealthCare Pharmaceuticals (Germany)
Cipla Limited (India)
Daiichi Sankyo Co., Ltd. (Japan)
Eli Lilly and Company (US)
Gilead Sciences, Inc. (US)
GlaxoSmithKline Plc (UK)
Nippon Shinyaku Co., Ltd. (Japan)
Pfizer, Inc. (US)
Sanofi S.A (France)
The Novartis Group (Switzerland)
United Therapeutics Corp. (US)
YM BioSciences, Inc. (Canada)
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Pulmonary Arterial Hypertension (PAH) Therapeutics in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by application, this report focuses on consumption, market share and growth rate of Pulmonary Arterial Hypertension (PAH) Therapeutics in each application, can be divided into
Application 1
Application 2
Application 3

【レポートの目次】

Table of Contents

Global Pulmonary Arterial Hypertension (PAH) Therapeutics Market Research Report 2016
1 Pulmonary Arterial Hypertension (PAH) Therapeutics Market Overview
1.1 Product Overview and Scope of Pulmonary Arterial Hypertension (PAH) Therapeutics
1.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Segment by Type
1.2.1 Global Production Market Share of Pulmonary Arterial Hypertension (PAH) Therapeutics by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Pulmonary Arterial Hypertension (PAH) Therapeutics Segment by Application
1.3.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Pulmonary Arterial Hypertension (PAH) Therapeutics Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Pulmonary Arterial Hypertension (PAH) Therapeutics (2011-2021)

2 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Market Competition by Manufacturers
2.1 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production and Share by Manufacturers (2015 and 2016)
2.2 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Pulmonary Arterial Hypertension (PAH) Therapeutics Manufacturing Base Distribution, Sales Area and Product Type
2.5 Pulmonary Arterial Hypertension (PAH) Therapeutics Market Competitive Situation and Trends
2.5.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Market Concentration Rate
2.5.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue (Value) by Region (2011-2016)
3.1 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production and Market Share by Region (2011-2016)
3.2 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Consumption by Regions (2011-2016)
4.2 North America Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue (Value), Price Trend by Type
5.1 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production and Market Share by Type (2011-2016)
5.2 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Market Share by Type (2011-2016)
5.3 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Price by Type (2011-2016)
5.4 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production Growth by Type (2011-2016)

6 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Market Analysis by Application
6.1 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Consumption and Market Share by Application (2011-2016)
6.2 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Manufacturers Profiles/Analysis
7.1 Actelion Pharmaceuticals Ltd. (Switzerland)
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Actelion Pharmaceuticals Ltd. (Switzerland) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Arena Pharmaceuticals, Inc. (US)
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Arena Pharmaceuticals, Inc. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Bayer HealthCare Pharmaceuticals (Germany)
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Bayer HealthCare Pharmaceuticals (Germany) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Cipla Limited (India)
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Cipla Limited (India) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Daiichi Sankyo Co., Ltd. (Japan)
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Daiichi Sankyo Co., Ltd. (Japan) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Eli Lilly and Company (US)
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Eli Lilly and Company (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Gilead Sciences, Inc. (US)
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Gilead Sciences, Inc. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 GlaxoSmithKline Plc (UK)
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 GlaxoSmithKline Plc (UK) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Nippon Shinyaku Co., Ltd. (Japan)
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Nippon Shinyaku Co., Ltd. (Japan) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Pfizer, Inc. (US)
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Pfizer, Inc. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Sanofi S.A (France)
7.12 The Novartis Group (Switzerland)
7.13 United Therapeutics Corp. (US)
7.14 YM BioSciences, Inc. (Canada)

8 Pulmonary Arterial Hypertension (PAH) Therapeutics Manufacturing Cost Analysis
8.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Pulmonary Arterial Hypertension (PAH) Therapeutics

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Pulmonary Arterial Hypertension (PAH) Therapeutics Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Market Forecast (2016-2021)
12.1 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue Forecast (2016-2021)
12.2 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production Forecast by Type (2016-2021)
12.4 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Consumption Forecast by Application (2016-2021)
12.5 Pulmonary Arterial Hypertension (PAH) Therapeutics Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List of Tables and Figures

Figure Picture of Pulmonary Arterial Hypertension (PAH) Therapeutics
Figure Global Production Market Share of Pulmonary Arterial Hypertension (PAH) Therapeutics by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Pulmonary Arterial Hypertension (PAH) Therapeutics Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production of Key Manufacturers (2015 and 2016)
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production Share by Manufacturers (2015 and 2016)
Figure 2015 Pulmonary Arterial Hypertension (PAH) Therapeutics Production Share by Manufacturers
Figure 2016 Pulmonary Arterial Hypertension (PAH) Therapeutics Production Share by Manufacturers
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue Share by Manufacturers
Table 2016 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue Share by Manufacturers
Table Global Market Pulmonary Arterial Hypertension (PAH) Therapeutics Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Pulmonary Arterial Hypertension (PAH) Therapeutics Average Price of Key Manufacturers in 2015
Table Manufacturers Pulmonary Arterial Hypertension (PAH) Therapeutics Manufacturing Base Distribution and Sales Area
Table Manufacturers Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type
Figure Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share of Top 3 Manufacturers
Figure Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share of Top 5 Manufacturers
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production by Regions (2011-2016)
Figure Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production and Market Share by Regions (2011-2016)
Figure Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production Market Share by Regions (2011-2016)
Figure 2015 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production Market Share by Regions
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue by Regions (2011-2016)
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue Market Share by Regions (2011-2016)
Table 2015 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue Market Share by Regions
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table China Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table India Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Consumption Market by Regions (2011-2016)
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Consumption Market Share by Regions (2011-2016)
Figure Global Pulmonary Arterial Hypertension (PAH) Therapeutics Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Consumption Market Share by Regions
Table North America Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Consumption, Import & Export (2011-2016)
Table Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Consumption, Import & Export (2011-2016)
Table China Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Consumption, Import & Export (2011-2016)
Table Japan Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Consumption, Import & Export (2011-2016)
Table India Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Consumption, Import & Export (2011-2016)
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production by Type (2011-2016)
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production Share by Type (2011-2016)
Figure Production Market Share of Pulmonary Arterial Hypertension (PAH) Therapeutics by Type (2011-2016)
Figure 2015 Production Market Share of Pulmonary Arterial Hypertension (PAH) Therapeutics by Type
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue by Type (2011-2016)
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Pulmonary Arterial Hypertension (PAH) Therapeutics by Type (2011-2016)
Figure 2015 Revenue Market Share of Pulmonary Arterial Hypertension (PAH) Therapeutics by Type
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Price by Type (2011-2016)
Figure Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production Growth by Type (2011-2016)
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Consumption by Application (2011-2016)
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Consumption Market Share by Application (2011-2016)
Figure Global Pulmonary Arterial Hypertension (PAH) Therapeutics Consumption Market Share by Application in 2015
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Consumption Growth Rate by Application (2011-2016)
Figure Global Pulmonary Arterial Hypertension (PAH) Therapeutics Consumption Growth Rate by Application (2011-2016)
Table Actelion Pharmaceuticals Ltd. (Switzerland) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Actelion Pharmaceuticals Ltd. (Switzerland) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Actelion Pharmaceuticals Ltd. (Switzerland) Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share (2011-2016)
Table Arena Pharmaceuticals, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arena Pharmaceuticals, Inc. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Arena Pharmaceuticals, Inc. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer HealthCare Pharmaceuticals (Germany) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare Pharmaceuticals (Germany) Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share (2011-2016)
Table Cipla Limited (India) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cipla Limited (India) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Cipla Limited (India) Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share (2011-2016)
Table Daiichi Sankyo Co., Ltd. (Japan) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Daiichi Sankyo Co., Ltd. (Japan) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Daiichi Sankyo Co., Ltd. (Japan) Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly and Company (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly and Company (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share (2011-2016)
Table Gilead Sciences, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gilead Sciences, Inc. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Gilead Sciences, Inc. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Plc (UK) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Plc (UK) Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share (2011-2016)
Table Nippon Shinyaku Co., Ltd. (Japan) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nippon Shinyaku Co., Ltd. (Japan) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Nippon Shinyaku Co., Ltd. (Japan) Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share (2011-2016)
Table Pfizer, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer, Inc. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pulmonary Arterial Hypertension (PAH) Therapeutics
Figure Manufacturing Process Analysis of Pulmonary Arterial Hypertension (PAH) Therapeutics
Figure Pulmonary Arterial Hypertension (PAH) Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Pulmonary Arterial Hypertension (PAH) Therapeutics Major Manufacturers in 2015
Table Major Buyers of Pulmonary Arterial Hypertension (PAH) Therapeutics
Table Distributors/Traders List
Figure Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production and Growth Rate Forecast (2016-2021)
Figure Global Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production Forecast by Regions (2016-2021)
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Consumption Forecast by Regions (2016-2021)
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Production Forecast by Type (2016-2021)
Table Global Pulmonary Arterial Hypertension (PAH) Therapeutics Consumption Forecast by Application (2016-2021)


★調査レポート[世界の肺動脈高血圧(PAH)治療市場2016] (コード:QYR61224868)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の肺動脈高血圧(PAH)治療市場2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆